{"id":10,"date":"2022-11-23T14:01:20","date_gmt":"2022-11-23T14:01:20","guid":{"rendered":"https:\/\/voxzogohcp-dev-001.azurewebsites.net\/en-us\/voxzogo\/?page_id=10"},"modified":"2026-06-11T19:53:12","modified_gmt":"2026-06-11T19:53:12","slug":"for-families-considering-therapy-voxzogo-vosoritide","status":"publish","type":"page","link":"https:\/\/www.voxzogo.com\/en-us\/","title":{"rendered":"For Families Considering Therapy | VOXZOGO\u00ae (vosoritide)\u202f"},"content":{"rendered":"
\n
<\/div>\n
<\/div>\n
<\/div>\n
<\/div>\n
\n
\n
\n

Here for you from the start\n<\/h1>\n

VOXZOGO is the first and only treatment FDA approved from birth for children with achondroplasia until growth plates close<\/h3><\/span>\n

Why VOXZOGO<\/a><\/p>\n \t\t\t\t

\n\t\t\t\t\t

Sophie, 9 months old, on VOXZOGO since 3 months old<\/p>\n\t\t\t\t <\/div>\n\t\t\t\t <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n

\n
\n
\n

Where would you like to begin?<\/h2>\n \n
\n Learn more about achondroplasia<\/a>\n Get started with VOXZOGO<\/a>\n Find resources and support<\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
\n\t
\n\t\t
\n\t\t
\n

The impact of VOXZOGO<\/h2>\n

Witness how VOXZOGO<\/span>® (vosoritide) helped to increase linear growth in children with achondroplasia<\/span>.<\/p>\n

View the Results<\/a><\/p>\n <\/div>\n \n

\n \n \n \n \n
\n
\n
\n \"Annika, <\/div>\n
\n \"Annika, <\/div>\n <\/div>\n

For illustrative purposes only, image scale is not matched.<\/p>\n<\/figcaption>\n <\/figure>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n

\n\t
\n\t\t
\n\t\t
\n

Chosen by over 5,000 families across the world<\/h2>\n

Hear why thousands of families felt confident VOXZOGO was the right choice for their infants and children with achondroplasia.<\/p>\n

Watch Their Stories<\/a><\/p>\n <\/div>\n \n

\n \n \n \n \n
\n
\n
\n \"Collage <\/div>\n
\n \"Collage <\/div>\n <\/div>\n <\/figure>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n
\n
\n
\n

An established history in achondroplasia<\/h2>\n \n
\n
\n

FIRST & ONLY<\/h3>\n \n

treatment FDA
\napproved from birth<\/p>\n <\/div>\n

\n

10+<\/h3>\n \n

years of clinical trial<\/span>
\nexperience in achondroplasia<\/p>\n <\/div>\n

\n

5,000+<\/h3>\n \n

families have chosen
\nVOXZOGO worldwide<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n

\n
\n
\n
\n

A commitment to the achondroplasia community<\/h2>\n <\/div>\n \n
\n

BioMarin has been dedicated to skeletal conditions for over 25 years—including 10+ years of clinical trial<\/span> experience in achondroplasia<\/span>. <\/strong>Whether you’re looking to connect with other caregivers for guidance, learn more about treatment by attending an educational event, or find specialized care near you, BioMarin is committed to providing resources to help the communities they serve continue to thrive.<\/p>\n <\/div>\n \n

\n \n \"\"\/ VOXZOGO Mentor Program<\/span>\n
<\/div>\n <\/a>\n \n \"\"\/ Educational Events<\/span>\n
<\/div>\n <\/a>\n \n \"\"\/ Achondroplasia Doctor Finder<\/span>\n
<\/div>\n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t \t\t\t\t\t\t\t\t

Widespread coverage to help get you started<\/h2>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t
\n\t\t\t \n
\n
\n \"\"\/ \n
\n

Over 96%<\/h4>\n \n

of insured patients
have secured coverage
for VOXZOGO*<\/p>\n <\/div>\n\n <\/div>\n<\/div>\n\n

\n
\n \"\"\/ \n
\n

Over 96%<\/h4>\n \n

of eligible families with 
commercial insurance paid $0 out of pocket for VOXZOGO*†<\/sup><\/small><\/p>\n <\/div>\n\n <\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n

\n
\n
\n \n
\n

See Support Offerings<\/a><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n

\n
\n\t\t
\n\t\t\t
\n
\n

Looking for more information about VOXZOGO?<\/h2>\n <\/div>\n
\n

Your local BioMarin representative can help you find answers.<\/p>\n \n

Connect Now<\/a><\/p>\n <\/div>\n <\/div> \n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n

\n
\n
\n \n
\n

*BioMarin RareConnections™ Data on file. Patients included are eligible VOXZOGO patients who have enrolled in BioMarin RareConnections and are on commercial therapy.
\n†<\/sup>With the BioMarin Co-Pay Assistance Program. Terms and Conditions apply. Valid only for patients with commercial prescription insurance coverage who have a valid prescription for an FDA-approved indication and who meet additional eligibility criteria. Not valid for prescriptions reimbursed, in whole or in part, by any federal, state, or government-funded insurance programs (for example, Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD, or TRICARE) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be able to use the program and patient must notify BioMarin RareConnections at 1-866-906-6100 to stop participation. Patients residing in or receiving treatment in certain states may not be eligible for some or all of the program elements. Patients may not seek reimbursement for value received from the program from any third-party payers. Additional restrictions may apply. Offer subject to change or discontinuance without notice. This assistance offer is not health insurance. See BioMarin-copay-terms.com for full Terms and Conditions.<\/small><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-10","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nVOXZOGO\u00ae | Supporting Growth in Children with Achondroplasia<\/title>\n<meta name=\"description\" content=\"VOXZOGO\u00ae (vosoritide) is an FDA-approved treatment for infants & children with achondroplasia. Explore how it works, clinical data, safety, & support resources.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.voxzogo.com\/en-us\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VOXZOGO\u00ae | Supporting Growth in Children with Achondroplasia\" \/>\n<meta property=\"og:description\" content=\"VOXZOGO\u00ae (vosoritide) is an FDA-approved treatment for infants & children with achondroplasia. Explore how it works, clinical data, safety, & support resources.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.voxzogo.com\/en-us\/\" \/>\n<meta property=\"og:site_name\" content=\"BioMarin Voxzogo Patient EN-US\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-11T19:53:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/\",\"url\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/\",\"name\":\"VOXZOGO\u00ae | Supporting Growth in Children with Achondroplasia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/#website\"},\"datePublished\":\"2022-11-23T14:01:20+00:00\",\"dateModified\":\"2026-06-11T19:53:12+00:00\",\"description\":\"VOXZOGO\u00ae (vosoritide) is an FDA-approved treatment for infants & children with achondroplasia. Explore how it works, clinical data, safety, & support resources.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"For Families Considering Therapy | VOXZOGO\u00ae (vosoritide)\u202f\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/#website\",\"url\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/\",\"name\":\"BioMarin Voxzogo Patient EN-US\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.voxzogo.com\\\/en-us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VOXZOGO\u00ae | Supporting Growth in Children with Achondroplasia","description":"VOXZOGO\u00ae (vosoritide) is an FDA-approved treatment for infants & children with achondroplasia. Explore how it works, clinical data, safety, & support resources.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.voxzogo.com\/en-us\/","og_locale":"en_US","og_type":"article","og_title":"VOXZOGO\u00ae | Supporting Growth in Children with Achondroplasia","og_description":"VOXZOGO\u00ae (vosoritide) is an FDA-approved treatment for infants & children with achondroplasia. Explore how it works, clinical data, safety, & support resources.","og_url":"https:\/\/www.voxzogo.com\/en-us\/","og_site_name":"BioMarin Voxzogo Patient EN-US","article_modified_time":"2026-06-11T19:53:12+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.voxzogo.com\/en-us\/","url":"https:\/\/www.voxzogo.com\/en-us\/","name":"VOXZOGO\u00ae | Supporting Growth in Children with Achondroplasia","isPartOf":{"@id":"https:\/\/www.voxzogo.com\/en-us\/#website"},"datePublished":"2022-11-23T14:01:20+00:00","dateModified":"2026-06-11T19:53:12+00:00","description":"VOXZOGO\u00ae (vosoritide) is an FDA-approved treatment for infants & children with achondroplasia. Explore how it works, clinical data, safety, & support resources.","breadcrumb":{"@id":"https:\/\/www.voxzogo.com\/en-us\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.voxzogo.com\/en-us\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.voxzogo.com\/en-us\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.voxzogo.com\/en-us\/"},{"@type":"ListItem","position":2,"name":"For Families Considering Therapy | VOXZOGO\u00ae (vosoritide)\u202f"}]},{"@type":"WebSite","@id":"https:\/\/www.voxzogo.com\/en-us\/#website","url":"https:\/\/www.voxzogo.com\/en-us\/","name":"BioMarin Voxzogo Patient EN-US","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.voxzogo.com\/en-us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/pages\/10","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/comments?post=10"}],"version-history":[{"count":428,"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/pages\/10\/revisions"}],"predecessor-version":[{"id":7305,"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/pages\/10\/revisions\/7305"}],"wp:attachment":[{"href":"https:\/\/www.voxzogo.com\/en-us\/wp-json\/wp\/v2\/media?parent=10"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}